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Differentially expressed genes during spontaneous lytic switch
of Marek’s disease virus in lymphoblastoid cell lines
determined by global gene expression profiling
William N. Mwangi,1,* Deepali Vasoya,2 Lydia B. Kgosana,1 Mick Watson2 and Venugopal Nair1
Abstract
Marek’s disease virus (MDV), an alphaherpesvirus of poultry, causes Marek’s disease and is characterized by visceral
CD4+TCRab+ T-cell lymphomas in susceptible hosts. Immortal cell lines harbouring the viral genome have been generated
from ex vivo cultures of MD tumours. As readily available sources of large numbers of cells, MDV-transformed
lymphoblastoid cell lines (LCLs) are extremely valuable for studies of virus–host interaction. While the viral genome in most
cells is held in a latent state, minor populations of cells display spontaneous reactivation identifiable by the expression of
lytic viral genes. Spontaneous reactivation in these cells presents an opportunity to investigate the biological processes
involved in the virus reactivation. For detailed characterization of the molecular events associated with reactivation, we used
two lymphoblastoid cell lines derived from lymphomas induced by pRB1B-UL47eGFP, a recombinant MDV engineered to
express enhanced green fluorescent protein (EGFP) fused with the UL47. We used fluorescence-activated cell sorting to
purify the low-frequency EGFP-positive cells with a spontaneously activating viral genome from the majority EGFP-negative
cells and analysed their gene expression profiles by RNA-seq using Illumina HiSeq2500. Ingenuity pathway analysis on more
than 2000 differentially expressed genes between the lytically infected (EGFP-positive) and latently infected (EGFP-negative)
cell populations identified the biological pathways involved in the reactivation. Virus-reactivating cells exhibited differential
expression of a significant number of viral genes, with hierarchical differences in expression levels. Downregulation of a
number of host genes including those directly involved in T-cell activation, such as CD3, CD28, ICOS and phospholipase C,
was also noticed in the LCL undergoing lytic switch.
INTRODUCTION
Marek’s disease virus (MDV) is a widely prevalent alphaher-
pesvirus of poultry, associated with Marek’s disease (MD)
and characterized by rapid-onset CD4+TCRab+T-cell
tumours at high incidence in susceptible hosts. Initial infec-
tion and subsequent spread of MDV occurs through the
inhalation of infectious virus in dust. After a short lytic
phase in B lymphocytes [~2–7 days post infection (d.p.i.)],
MDV establishes a life-long latent infection in T-lympho-
cytes. Subsequently, the MDV lifecycle is completed by the
virus replication in the feather follicle epithelium, the site
from which infectious cell-free virus is shed into the
environment through the dander [1, 2]. Neoplastic
transformation of latently infected CD4+ lymphocytes in
susceptible birds results in lymphomas. These tumours and
the lymphoblastoid cell lines (LCLs) derived from them are
mainly monoclonal with clonally restricted T cell receptor
(TCR) profiles [3–5].
Latency is a distinct feature of herpesvirus infections, where
the virus silently persists in the infected cell with occasional
reactivation events leading to lytic infection. For example, in
humans, all herpesviruses initially cause a primary infection
before entering a latent state from which it can reactivate
and cause recurrent lesions [6]. In herpes simplex virus type
1 (HSV-1) and HSV-2 [7, 8] infections, reactivation is trig-
gered by various factors attributed to either the virus itself,
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host genetics or the surrounding environment. For example,
the appearance of HSV cold sores results from a wide range
of environmental stressors, including mental stress, fatigue,
hormonal changes, dental surgery, cranial trauma, fever and
exposure to UV light [9]. Understanding the mechanistic
events during reactivation is therefore of great interest. Var-
ious in vitro culture systems to elucidate the pathways and
molecular events involved in reactivation have indicated the
roles of both host factors such as neuronal/nerve growth
factor (NGF) [10–13] and viral factors such as latent associ-
ated transcripts (LATs), VP16, ICP0 [14–18].
Compared to tudies on human herpesviruses, little is known
about the factors that regulate MDV latency and reactiva-
tion [19]. The potential involvement of epigenetic factors
such as DNA methylation and histone modifications of the
repeat regions of the viral genome in the maintenance of
latency have been demonstrated [20]. It was also shown that
MDV-1 telomeric repeats are essential for efficient integra-
tion, enhanced tumour formation and capacity for reactiva-
tion [21]. These results suggested the roles of multiple
factors, both for efficient maintenance of the virus in the
latent state and mobilization of the virus genome during
reactivation. Studies on LCLs derived from tumours
induced by recombinant MDV-expressing lacZ marker
showed that the marker gene was expressed with the same
kinetics as lytic viral genes pp38, US1, gB, gI, and US10 after
treatment with 5¢-iododeoxyuridine [22]. This study also
showed that MDV-encoded oncoprotein Meq, although
normally associated with transformation and latency, could
be detected in cells expressing the marker and the lytic anti-
gens. Indeed, Meq expression in lytic and latent/tumour
cells was also demonstrated in other independent studies
[23]. Other studies characterized the cell surface phenotypes
of lytically infected cells and transformed cell lines. For
example, MHC class II was upregulated during lytic infec-
tion on the surface of an MDV-derived cell line, RP1, upon
bromodeoxyuridine-induced transcriptional activation [24].
This was considered a unique response to MDV and is
thought to assist in enhancing cell-to-cell contact and
spread of MDV to activated T-lymphocytes. On the other
hand, downregulated surface expression of MHC Class I
(BF) glycoproteins by blocking their transport to the cell
surface during active, but not latent, infection of chicken
cells has also been reported [25]. Taken together, these stud-
ies showed the involvement of both host and viral factors in
the latency to lytic switch of MDV.
The work reported here aimed to investigate differential
gene expression during spontaneous lytic switch of MDV
within the microenvironment of the transformed cell line.
Previous reports, including our preliminary work, demon-
strated that cell lines such as MSB-1 contain 1–10% of the
cells displaying lytic phenotype, as demonstrated by
expression of pp38 [26]. However, the mechanism and the
microenvironment by which MDV is reactivated in the
small proportion of cells in these cell lines remain unknown.
The presence of these lytically infected subpopulations in
the cell lines suggests a process of spontaneous reactivation,
and these cells provide a unique opportunity to understand
the pathways involved in MDV lytic switch.
In the present study, we established two LCLs from tumours
induced by pRB1B-UL47eGFP virus [27] as a tool to study
spontaneous lytic switch of MDV. We have recently used
transmission electron microscopy to demonstrate morpho-
genesis of herpesvirus particles in the enhanced green fluo-
rescent protein (EGFP)-expressing cells of one of these cell
lines [28]. Global gene expression profiling using RNA-seq
was used to examine the transcriptome changes associated
with lytic switch. We present detailed analysis of the global
changes in the host and viral transcriptome of cells under-
going spontaneous lytic switch of MDV from latency in
these LCLs.
RESULTS
Raw data
The raw sequencing data have been submitted to the Euro-
pean Nucleotide Archive under accession number
PRJEB14979.
Recombinant pRB1B-UL47eGFP MDV and
generation of cell lines
Inbred P line (MHC B19/19) white leghorn chickens infected
with pRB1B-UL47eGFP [27] showed expression of EGFP in
the feather follicle epithelium (data not shown) confirming
its use as a potential marker for lytically infected cells. Two
cell lines (NWB-s and 3867-k) were established from pri-
mary lymphomas from spleen and kidney of two separate
birds respectively following serial passages of ex vivo tumour
cell cultures. Flow cytometric analyses revealed that
although majority of the cells in culture were EGFP , the
two cell lines demonstrated continued presence of a minor
population of EGFP+ cells during culture (Fig. 1). Overall
percentages of the EGFP+ cells were consistent with the
numbers of pp38+ cell populations in reactivating LCLs pre-
viously reported [22, 29]. Compared to the multiple steps of
fixation and permeabilization to demonstrate the virus-
encoded lytic proteins in the cytoplasmic compartment of
conventional MDV-transformed LCLs, NWB-s and 3867-k
cell lines with the readily demonstrable EGFP marker were
quicker for sorting of reactivating cells with minimal
manipulation. Moreover these cell lines contained monoclo-
nal CD4+ cells of Vb1 TCR types (data not shown) a profile
demonstrated for majority of MDV derived LCL [3]. Thus
these two LCLs formed excellent samples for comparing
changes in gene expression between latency and lytic switch
in EGFP  and EGFP+ populations respectively.
RNA-seq of EGFP
+
versus EGFP
 
cell populations
Single-cell suspensions of the cultures for the two cell lines
were used to purify EGFP+ and EGFP  subpopulations
using fluorescence-activated cell sorting (FACS). The puri-
fied cells were used to extract high quality RNA for subse-
quent sequencing. Total reads and the insert sizes from the
subpopulations of cells were comparable (Table 1). Filtered
Mwangi et al., Journal of General Virology 2017;98:779–790
780
Downloaded from www.microbiologyresearch.org by
IP:  82.33.139.132
On: Sun, 07 May 2017 16:38:03
sequencing reads were mapped to Gallus gallus (Ensembl
release 74) and gallid herpesvirus 2 (MDV type 1,
NC_002229) reference genome sequences. The total num-
bers and percentages of aligned reads for host and virus
genomes were comparable between the two cell lines. The
gene expression profiles in EGFP  and EGFP+ populations
were clearly separable in terms of biological coefficient of
variation (data not shown). The proportion of host chicken
genes that accounted for more than 99% of the reads in the
EGFP  latent cell populations in both cell lines were
reduced to 76 and 83% in the EGFP+ activated population
in the two cell lines. This change in the expression of host
genes was accompanied by an increase in the proportion of
reads of viral genes to 16.23 and 23.22% in the EGFP+
NWB-s and 3867-k, respectively (Table 1), further confirm-
ing the lytic switch of the virus in these populations. We
also examined the numbers of reads of EGFP transcripts in
the latent and reactivated cell populations of the two cell
lines. As expected, the two reactivated cell populations
showed a 100–1000-fold increase in EGFP expression com-
pared to the latent cells (Table 1).
Differentially expressed (DE) genes in positive and negative
samples that are potentially associated with reactivation of
MDV are also likely to be involved in a number of biological
processes that play a role in immune evasion or modulation,
transformation and virus lifecycle. We therefore aimed to
identify all the DE genes to decipher their association with
pathways and cellular networks. To this end, edgeR software
was used to perform pair-wise tests separately between
EGFP  and EGFP+ from NWB-s and 3867-k cell line data.
DE genes were further filtered at a false discovery rate
(FDR) <0.05 (Fig. 2a).
DE host genes. A high number of DE genes were observed
between EGFP+ and EGFP  samples in the two cell lines
using 0.25 biological coefficient of variation. Interestingly,
there were similarities in the profiles of DE genes in the latent
and reactivated populations of the two cell lines. The 3867-k
cell line showed a total of 2093 DE genes, of which 1262 were
downregulated and 831 upregulated. The NWB-s cell line
showed a total of 1975 DE genes of which 1092 were downre-
gulated and 883 upregulated. The results also showed that
1478 DE genes, including 851 downregulated and 627 upreg-
ulated genes, were common in both lines (Fig. 2b). In order
to reveal the relative expression pattern of these significant
DE genes in the NWB-s and 3867-k cell lines, the count per
million (CPM) of the normalized expression values of these
genes in all four samples were displayed as heat maps where
genes were clustered using correlation (Fig. 3). This analysis
revealed a remarkable similarity in the expression profiles
between the two cell lines. A list of the top 100 upregulated
and downregulated genes in the EGFP+ subpopulation from
each LCL, ranked by order of significance, is shown in
Table S1(a–d) (available in the online Supplementary
Material).
DE viral genes. Analysis of the viral transcripts [30] from
both cell lines revealed 82 DE genes, all of which were
upregulated in the EGFP+ population of reactivating cells as
opposed to the EGFP  latent cell population. In order to
determine the relative expression pattern of the significantly
expressed viral genes in the NWB-s and 3867-k cell lines,
normalized expression values of these genes in all four sam-
ples were displayed as heat maps where genes were clustered
using correlation (Fig. 4). CPM values for viral transcript
from both LCLs are presented in Table S2(a). The CPM val-
ues were also used to analyse relative changes in the levels of
each transcript between the two populations. This analysis
showed the remarkable similarities of the two cell lines in
0.00 % 0.02 %
99.98 % 0.00 %
0.03 % 0.07 %
95.37 % 4.53 %
0.02 % 0.02 %
91.62 % 8.34 %
MSB-1 3876-k NWB-s
FL1 (EGFP)
F
L
2
 (
P
E
)
Fig. 1. Use of recombinant fluorescent MDV virus to identify lytic
switch in established MDV LCL. Two cell lines (3867-k and NWB-s)
were generated from tumours derived from P line birds infected with
pRB1B- UL47eGFP. Dot plot shows unstained MSB-1 cell line as a neg-
ative control; Unstained 3867-k cell line showing approximately
4.5% cells positive for UL47eGFP expression and unstained NWB-s
cell line showing approximately 8.3% cells positive for UL47eGFP
expression.
Table 1. Summary of RNA-seq reads aligned to Gallus gallus, MDV and EGFP
LCL Identifier Total reads Insert size
(nt)
Number of reads (%) aligned with
Gallus gallus MDV EGFP
NWB-s EGFP  155 401 762 167 128 254 562
(99.56%)
556 004
(0.44%)
1708
(0.001%)
EGFP+ 130 052 456 178 79 874 012
(83.77%)
15 470 241
(16.23%)
126 931
(0.10%)
3867-k EGFP  145 789 034 166 122 750 138
(99.78%)
270 291
(0.22%)
363
(0.0002%)
EGFP+ 148 125 420 165 78 560 470
(76.78%)
23 758 049
(23.22%)
297 887
(0.20%)
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relation to the rankings of the transcripts based on highest
and lowest fold changes (Table S2b). Amongst the tran-
scripts that showed the highest relative fold changes were
the transcriptional regulator ICP4, envelope glycoprotein E,
protein SORF3, envelope glycoprotein I, virion protein US2
and tegument protein VP13. On the other hand, MDV-
encoded proteins such as MEQ oncoprotein, LORF5, heli-
case-primase helicase subunit, myristylated tegument
protein CIRC and protein LORF4 showed the least levels of
changes in expression (Table S2b).
Validation of gene array results
Graphical representation of fold-change values obtained
from RNA-seq data for 12 selected genes is shown in Fig. 5
(a). This analysis indicated that ATP-binding cassette trans-
porter (ABCA1), Tp63, inducible T-cell co-stimulator
(ICOS), putative CCR8, putative CCR5, lipoprotein lipase
(LPL), Huntingtin interacting protein 1 (HIP1), CD4 tran-
scripts were downregulated in the EGFP+ cells relative to
the EGFP  cells. Moreover, CD1b, CD1c and CD83 tran-
scripts were upregulated in the EGFP+ cells relative to the
EGFP  cells. Furthermore, pp38, an MDV viral transcript
expressed during lytic infection, was also upregulated in the
EGFP+ cells. Expression changes of transcripts selected
from the downregulated and upregulated genes were ana-
lysed by using the SYBR-green RT-qPCR method. Analysis
of expression of each of these genes relative to the internal
control (HMBS transcript) in the EGFP+ cells relative to
EGFP  cells indicated that ABCA1, Tp63, ICOS, putative
CCR8, putative CCR5, LPL, HIP1 CD4 were downregulated
while CD1b, CD1c, CD83, pp38 transcripts were upreg-
ulated (Fig. 5b). This observation was consistent with data
obtained by RNA-seq with all selected genes comparable in
the direction and relative magnitude from these two
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Fig. 2. Analysis of DE genes. (a) The edgeR smear plot of log fold change (FC) against the average log count per million (CPM). (Left)
DE genes in NWB-s EGFP+ versus NWB-s EGFP . (Right) DE genes in 3867-k EGFP+ versus 3867-k EGFP . Blue horizontal lines repre-
sent four fold changes. The FDR cut-off 0.05 was applied to display the significantly DE genes, which are highlighted in red. (b) Venn
diagram representing the common upregulated and downregulated genes in the two LCLs.
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independent expression analysis platforms, thus validating
the data generated by the RNA-seq method.
Pathway analysis
In order to investigate biological functions of DE genes,
accession numbers of genes of interest were imported into
Ingenuity Pathway Analysis (IPA) along with their corre-
sponding expression P-values and log fold-change values.
This enabled comparison of over-represented signalling and
metabolic pathways and gene functions for EGFP+ and
EGFP  samples. The top recognized pathways of upreg-
ulated and downregulated genes represented in both EGFP+
samples are shown in Fig. 6. Since the samples were derived
from MDV-transformed T-cell lines, genes associated with
immune evasion/modulation, viral infection and tumour
were expected to be DE in this data set. Indeed, the top sig-
nificantly DE genes were those involved in immunological
disease, infectious disease, inflammatory response and met-
abolic disease. Moreover, they were associated with molecu-
lar functions such as cellular development, cell-to-cell
signalling and interaction, cell morphology, cellular func-
tion and maintenance, and cellular movement.
DISCUSSION
MD is a major disease of poultry with huge economic and
animal welfare significance, and it is also an excellent natu-
ral biomedical model for rapid-onset T-cell lymphomas.
Recent research on this disease has led to major break-
throughs in our understanding of the basic transforming
attributes of MDV such as the role of virus-encoded
oncoprotein Meq and oncomicroRNA miR-M4 [23, 31].
Moreover, the availability of infectious bacterial artificial
chromosome (BAC) clones of MDV allowing the generation
of recombinant viruses expressing fluorescent marker genes
has now enabled studies looking into the role of viral gene
products in replication and pathogenesis. At the same time,
recent advances in the chicken genome annotation and
associated bioinformatics tools have enabled more in-depth
analysis of gene expression profiles in MDV-infected cells.
Data generated from such studies are beginning to provide
insights into the complex MDV–host interactions.
The work presented here aimed to analyse the changes in
global transcription during the switch from latency to lytic
infection in an MDV-transformed cell line model. This is of
major interest because MDV, similar to other herpesviruses,
is an obligate intracellular parasite, dependent on the host
cell machinery for replication during active lytic infection.
Latency and reactivation are indeed hallmarks of persistent
infections seen in all herpesviruses, where the viral lifecycle
involves both silent and productive infection without rap-
idly damaging the host cells [32]. Reactivation, a process
which in most cases is associated with disease symptoms
and complications, may be provoked by a combination of
external and/or internal cellular stimuli [6].
In MD tumour cells and LCLs, it is increasingly becoming
clear that the latency is maintained through epigenetic
mechanisms that include methylation and chromatin modi-
fications [19, 20, 33]. In order to gain insights into the lytic
switch process in MDV-transformed LCLs, two cell lines,
3867-k and NWB-s, were generated from kidney and spleen
tumours, respectively, induced in P line birds infected with
pRB1B-UL47eGFP, a recombinant virus expressing EGFP
NWB-s EGFP+ 3867-k EGFP+ NWB-s EGFP– 3867-k EGFP–
G
e
n
e
s
1
.0
0
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Fig. 3. Heat map of DE host genes in latent and reactivated LCLs.
Comparisons of the relative expression levels of the genes in EGFP+
populations of 3867-k and NWB-s LCLs compared with EGFP  popula-
tions. The expression levels are highlighted in blue and yellow scale.
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marker as a fusion protein with UL47 [27]. As the viral
genomes are maintained in a latent state, EGFP expression
is shut off in both cell lines. However, we found that a small
proportion of cells spontaneously expressed EGFP at levels
similar to those of MDV lytic genes such as pp38 seen in
cells with reactivating virus [22, 29]. We have also recently
NWB-s 
EGFP+
3867-k
EGFP+
NWB-s 
EGFP–
3867-k 
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shown that these cells produce virus particles [28]. The abil-
ity to isolate these spontaneously reactivating fluorescent
cells presented an ideal resource to analyse, with minimal
manipulation, cell populations showing viral reactivation in
relation to the majority latent cell population.
This analysis generated in excess of 2000 DE genes, consis-
tent with the extensive intracellular, biochemical and mor-
phologic changes that accompany the transition from the
latency phase to the reactivated state. However, there is lim-
ited information regarding the role of most of these gene
products and the biological/molecular pathways during
MDV infection. Nevertheless, by inferring to the known
roles in the relatively well-studied mammalian system, and
based on historical anecdotal evidence, we selected a few
candidates from the significantly highly expressed gene list
for exploring the possible roles for their differential expres-
sion within the context of active viral infection. Our data
revealed that changes in the host transcription in
the reactivating population involved downregulation of key
cellular pathways such as TCR, co-stimulatory molecules
and factors in associated signalling systems. This suggested
that MDV reactivation resulted in inhibition of the common
T-cell activation pathways such as TCR, ICOS and CD28.
TCR ligation initiates a central signalling pathway critical
for regulating T-cell biology. It is therefore not surprising
that MDV, like many other lymphotropic viruses, have
evolved mechanisms to modulate TCR signalling. In this
regard, it has been documented that T-lymphotropic viruses
such as human T-lymphotropic virus type 1, herpesvirus
saimiri and human herpesvirus 6 can all modulate the TCR
function [34–37]. However, direct interference of the TCR
pathways by MDV has not yet been demonstrated. Never-
theless, it is known that MDV preferentially infects activated
T-cells [19] and therefore one could speculate that the virus
may have yet-unidentified mechanisms for modulating the
TCR pathways and related molecular interactions. Given
the central role of the PI3-kinase signalling pathway during
reactivation and the shared role of kinases during immune
receptor signalling pathways, it is not surprising that reacti-
vation in an immune cell would inevitably involve manipu-
lation of the key immune receptor signalling pathway.
Consistent with this view, a number of genes, including
ICOS, CD4, lymphocyte-specific protein tyrosine kinase
(LCK), zeta-chain (TCR)-associated protein kinase 70 kDa
(ZAP70), IL2-inducible T-cell kinase (ITK), phospholipase
C, gamma 1 (PLCy1), IL-2R and CD3 chains, were downre-
gulated following reactivation. This transcription profile
indicated a scenario where genes either directly or indirectly
involved in TCR signalling are downmodulated. IPA analy-
ses showed that ICOS is mainly involved in iCOS-iCOSL
signalling in T-helper (Th) cells, primary immunodeficiency
signalling and the Th cell differentiation pathway. More-
over, ICOS has many upstream regulators such as IL2, TNF,
TCF3, miR-29b, TCR, IL15, CSF2, CD3, ionomycin, miR-
66, cyclosporine A, STAT3, CD28, IL4 and NFkB, among
others. Due to these interactions, it is involved in several
functions concerned with cell death and survival, morphol-
ogy, signalling, cell-mediated immune response, tumour
morphology and cancer, immune cell trafficking, and
inflammatory response. Furthermore, ZAP70 was also
downregulated and IPA analysis indicated that it may be
associated with many pathways such as ICOS signalling in
Th, CD28 signalling, calcium-induced T-lymphocyte apo-
ptosis, phospholipase C-signalling, T-cell receptor signalling
and PKC0 signalling in T-lymphocytes. These pathways
constitute an intricate web of interactions that are essential
during T-cell activation and downregulation of some or in
this case the majority of these gene products and would
inevitably inhibit activation of the affected T-cells.
In contrast, some genes, such as those involved in immune
regulation, were found to be upregulated. For example,
MHC-II transcripts were upregulated in the reactivated
cells. Indeed, upregulation of MHC-II was previously
reported in primary MDV-infected cell populations [24],
and was hypothesized to be one possible way that the
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Fig. 5. Expression of NWB-s LCL genes selected for validation. (a).
Fold-change values obtained from RNA-seq data: ABCA1, Tp63, ICOS,
putative CCR8, putative CCR5, LPL, HIP1, CD4 were downregulated,
and CD1b, CD1c, CD83, pp38 genes were upregulated. (b) Expression
was determined by RT-qPCR. Expression was analysed relative to the
internal control (HMBS) in the EGFP+ cells relative to the EGFP  cells
and expressed as fold change (2 DDCT). The expression pattern where
ABCA1, Tp63, ICOS, CCR8, CCR5, LPL, HIP1, CD4 were downregulated
and CD1b, CD1c,CD83, pp38 genes were upregulated is similar to that
obtained by RNA-seq. Error bars indicate standard deviation (SD).
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strictly cell-associated MDV virus is propagated into new
target cells resulting in enhanced MHC–TCR interaction.
Similarly, upregulation of other immune system modulat-
ing/regulating genes (such as CD83) was observed. CD83 is
mainly involved in crosstalk between dendritic cells and
natural killer cells, dendritic cell maturation and TREM1
signalling. In addition, CD83 has many upstream regulators
such as IL2, TNF, TGFB1, lipopolysaccharide, dexametha-
sone, IL15, CD40L6, CSF2, NR3CL, CD3, STAT3 and
NFkB, hence its involvement in functions of cellular devel-
opment, growth and proliferation. Furthermore, soluble
CD83 has immunosuppressive roles such as the inhibition
of T-cell stimulation [38], which would presumably affect
the functional ability of the immune cells and benefit viral
replication. We speculated that it is this inhibitory role that
might be of relevance to its upregulation in cell-bearing
actively replicating virus. Interestingly, in addition to the
protein coding genes, we also found that gga-miR-142
(ENSGALG00000018344) is in the top 100 downregulated
genes in the activated EGFP+ cell population in both NWB-
s and 3867-k cell lines (Table S1b, d respectively). We have
previously reported that gga-miR-142 is highly expressed in
MDV-transformed LCLs such as MSB-1 [39], and its down-
regulation following lytic switch in both cell lines could be
functionally relevant. Based on the gene expression profiles
and pathway analysis, it appears that the final outcome of
the reactivation process in MDV-transformed LCLs is to
dampen the immune responsiveness and activation status of
the T-cells. Such a process may provide a direct benefit to
the virus by rendering the actively infected host cell unable
to control viral replication.
Our studies also showed that other metabolic pathways
such as those involved in the lipid metabolism (ABCA1,
ABCG1, ABCG4) were also affected in the reactivating cell
population. IPA showed that ABCA1 is involved in three
major pathways: LXR/RXR activation, PPARalpha/RXRal-
pha activation and LPS/IL1 mediated inhibition of RXR
function, which in turn leads to multifunctional pathways.
Although the involvement of these metabolic pathways has
not been previously reported in MD, impairment of these
pathways is known to be associated with HIV infectivity
[40] and increased risk of atherosclerotic plaque formation
and coronary artery disease. Interestingly, a phenomenon
referred to ‘foamy’ cell development in arterial lesions has
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5.01E-07, 5.13E-06
1.02E-06, 2.69E-06
6.17E-06, 2.51E-04
1.26E-06, 6.76E-08
6.03E-06, 1.38E-04
7.24E-05, 6.31E-06
9.55E-05,1.55E-03
1.00E-05, 4.37E-07
1.00E-05, 7.41E-05
1.00E-03,1.95-
E-04
1.05E-04, 2.69E-04
7.59E-06, 1.07E-05
3.63E-06, 7.59E-06
2.51E-05, 7.94E-07
1.48E-05, 1.66E-08
4.17E-04, 1.70E-04
2.09E-04, 2.24E-03
7.76E-05, 7.08E-04
1.70E-03, 7.59E-03
1.23E-04, 7.41E-04
4.79E-05, 7.41E-04
6.31E-03, 6.17E-02
1.07E-04, 7.59E-06
5.89E-04, 2.04E-02
2.75E-04, 1.02E-04
NF-KB activation by viruses
iCOS-iCOSL signalling in T-helper cells
Phospholipase C signalling
CD28 signalling in T-helper cells
PTEN signalling
PI3K signalling in B lymphocytes
Rac signalling
T-Cell receptor signalling
Tec kinase signalling
Axonal guidance signalling
ILK signalling
Signalling by Rho family GTPases
Calcium-induced T-lymphocyte apoptosis
Regulation of IL-2 expression in activated and anergic T-lymphocytes
PKCθ signalling in T-lymphocytes
NF-KB signalling
Protein kinase A signalling
TNFR2 signalling
Molecular mechanisms of cancer
Virus entry via endocytic pathways
Leukocyte extravasation signalling
Death receptor signalling
Integrin signalling
IL-8 signalling
B-Cell receptor signalling
0 5 10 15 20 25 30 35 40 45 50 55 60 65
Fig. 6. Top canonical pathways of DE genes in EGFP+ cells from NWB-s and 3867-k LCLs. All DE genes were submitted as a group.
P-values indicating the significance of each pathway are shown starting with those for NWB-s followed by those for 3867-k.
Mwangi et al., Journal of General Virology 2017;98:779–790
786
Downloaded from www.microbiologyresearch.org by
IP:  82.33.139.132
On: Sun, 07 May 2017 16:38:03
also been observed following MDV infection [41]. More-
over, infection of cultured chicken arterial smooth muscle
cells with MDV led to significant alterations in cholesterol
metabolism which contributed to the 7–10-fold increase in
free and esterified cholesterol accumulation in these cells,
partly due to decreased excretion of free cholesterol [42].
Based on past reports and the current data, we would
hypothesize that cellular lipid metabolism and membrane
structures such as lipid rafts may be modified to enable viral
assembly, envelopment and egress during reactivation and
active MDV replication.
As expected, we also observed the differential expression of
multiple viral genes in the reactivating cell populations from
both cell lines (Fig. 4). During herpesvirus reactivation,
multiple interactions between the virus gene products and
the host cellular pathways do occur. These host–viral inter-
actions occur at various levels; probably starting with the
primary role in initiation of reactivation process itself and
the subsequent secondary role in maintenance of reactivated
state mainly concerned with regulation of active viral repli-
cation during lytic infection including ensuring a permissive
cellular environment. Within the well-studied human HSV
reactivation, only a handful of viral proteins have been
implicated in initiation of reactivation including immediate
early (IE) proteins ICPO, ICP4 and others such as viral thy-
midine kinase and tegument protein VP16 [6, 18, 43].
In our global transcriptome analysis study described here it
is rather difficult to distinguish the role played by individual
viral products for various outcomes. This would require fur-
ther tailored studies that employ overexpression or knock-
out/knockin studies of potential candidate genes in a similar
cellular environment. However, it is evident from the list of
DE viral genes that a pattern of upregulation was observed
with some viral transcripts that encode proteins with
a reported reactivation role in other herpesviruses and
hence the potential significance of their upregulation can be
inferred. These included a clear upregulation of transcripts
for products with reported reactivation activities in HSV
systems such as ICP4 and VP16, with ICP4 ranked second
and fourth top upregulated transcript in the NWB-s and
3867-k cell lines, respectively. Thymidine kinase was also
moderately upregulated in both cell lines.
Although the absolute requirement for ICP4 and viral thy-
midine kinase in HSV reactivation remains unclear and lack
consensus from multiple independent studies, the involve-
ment of VP16 in reactivation is well documented [17].
VP16 is classified as a late gene protein but previous studies
demonstrated that it is expressed de novo (unaffected by
normal modulation of late gene expression) as a pre-IE gene
in neurons following reactivation [44]. Functionally, VP16
is able to transactivate the five IE HSV genes and initiate the
viral lytic cycle. The mechanism of action involves interac-
tion with host-cell proteins including host-cell factor-1
(HCF-1), a cell-cycle regulator and octomer binding pro-
tein-1 (Oct-1), a POU domain transcription factor, to form
the VP16-induced complex that binds to TAATGARAT
elements within the five HSV-1 IE gene promoters [17].
Even more significant is the report that viral mutants that
lack the transactivation function of VP16 do not exit the
latent state in vivo and have no detectable viral proteins dur-
ing latency [44]. For this reason, VP16 is a potential candi-
date for anti-HSV therapy. Although the kinetics of
expression of most MDV genes is not well studied, upregu-
lation of VP16 among the other viral transcripts in the
EGFP+ cell population in our RNA-seq data would suggest
a possible role in the MDV reactivation process that is likely
to involve a similar mechanism to that in HSV.
Also notable was upregulation of various genes encoding for
viral proteins involved in virus assembly, such as envelope
glycoprotein E, I, D, B, M K and various tegument proteins
such as tegument protein VP13, UL14, Vp22, UL16, UL51.
Also on this list of upregulated genes are glycoprotein C and
US2, previously reported to be associated with the horizon-
tal transmission of the virus [45]. Moreover, it was also
noted that the expression of viral genes was not random
across the whole genome. Viral genes located in the unique
short (US) regions appeared to be overrepresented among
the most highly upregulated genes (with all DE US tran-
scripts ranked among the top 15 positions in each cell line).
The significance of this pattern of expression is yet to be
determined.
In summary, we demonstrated differential expression of
multiple host and viral genes in the lytic switch process
within two independent MD-derived LCLs as indicated by
RNA-seq data. Although linking the DE genes to direct or
indirect host–virus interaction events, and hence decipher-
ing the mechanistic basis of lytic switch in MDV, is beyond
the scope of this study, the data could nonetheless aid in
identifying potential host candidate genes and/or pathways
that are prime targets of modulation by the virus during the
process of lytic switch. Taking into consideration the fact
that MDV is a model transforming herpesvirus and looking
at the examples of selected DE genes described above, the
data could provide insights into several interesting areas.
Firstly, this data may provide useful indicators of
the pathways involved in manipulation of host cellular
mechanisms by the virus to maintain latency and sustain
the tumour microenvironment, such as modulation of the
host cell proliferation. Secondly, this data may also provide
useful indicators regarding modulation of the host response
in cells harbouring reactivated virus, possibly to escape pre-
sentation and or recognition by the host immune system
and the viral genes involved. It is conceivable that regulation
of latency and lytic switch observed in vitro in these two
LCLs may be different to in vivo events. Nonetheless, deci-
phering such differences in these tumour cell lines would
greatly contribute to our current understanding of host–
virus interaction in herpesvirus biology, especially as the
mechanisms and the determinants of the relationship
between MDV latency and transformation remain unclear.
However, the work reported here reveals a list of possible
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candidate genes that could be crucial in future studies aimed
at defining MDV latency.
METHODS
Experimental infection
Inbred P line (MHC, B19/19) specific pathogen-free (SPF)
white leghorn chickens were maintained at the Poultry Pro-
duction Unit of the Pirbright Institute. One-day-old birds
were infected with 1000 p.f.u. dose of pRB1B-UL47eGFP
virus [27] by intra-abdominal injection as described previ-
ously [46, 47]. All experiments were carried out under spe-
cific project licences issued by the UK Home Office.
Tumour cell preparations, cell culture and
maintenance of LCLs
Tumours were aseptically removed from birds at post mor-
tem examination and lymphocytes prepared by Histopaque-
1083 density-gradient centrifugation and LCLs established
using methods described previously [3]. LCLs were adapted
to grow at 38.5

C in 5% CO2 in RPMI 1640 medium con-
taining 10% foetal bovine serum (FBS), 10% tryptose phos-
phate broth and 1% sodium pyruvate. Methods of the
maintenance of MSB-1 have been described previously [48].
Flow cytometry and sorting
Single-cell suspensions of cultured LCL were washed twice
with PBS containing 5% FBS with centrifugation at 450 g
for 5min at room temperature. The cell pellets were sus-
pended in cold PBS/5% FBS containing 1 µM DAPI for
subsequent exclusion of dead cells. EGFP+ and EGFP  sub-
populations were sorted by FACS using FACSAria II (BD
bioscience) to a purity of over 93%. Cells were sorted at five
different passage levels (21–25 for NWB-S and 48–52 for
3867-k cell lines) for each subpopulation. To maintain rela-
tive uniformity during sorting, aliquots of cells were
removed from culture in batches of a maximum 1107 cells
at a time and immediately sorted.
RNA isolation
Cells were disrupted by suspension in RLT buffer (QIAGEN)
and stored at  80

C. RNA was prepared from pooled cells
sorted at the five different passage levels for each subpopula-
tion to a total of four pooled RNA samples. RNA was
extracted with the RNeasy Mini kit (QIAGEN) according to
the manufacturer’s instructions. Contaminating DNA was
digested with RNase-free DNase 1 (QIAGEN) on a column
for 15min at room temperature. RNA was eluted with 50 µl
RNase-free water (QIAGEN) and stored at 80

C.
Table 2. Primer sequences for qRT-PCR
Gene Type Sequence Amplicon size (bp)
ABCA1 Forward 5¢-CCTCTGTTTATCTTCTTCATCCTGATC-3¢ 106
Reverse 5¢-AATGTTCCTGCTGAGGGCATA-3¢
Tp63 Forward 5¢-CCTCTCCATGCCTTCAACGT-3¢ 114
Reverse 5¢-CGTGAAATAATCCACACAGGATGA-3¢
ICOS Forward 5¢-ACACTGCTGATTCTTATTCCTTAAGTGA-3¢ 163
Reverse 5¢-TACATTGCCACTTGAAAGAAACCTA-3¢
CCR8 Forward 5¢-AACTGACTGCCTTGTGGGTTTATAT-3¢ 202
Reverse 5¢-TGGAAATCCGCCAGCAA-3¢
CCR5 Forward 5¢-CGGTTTAGCGTTACTCTTGATGTAATAA-3¢ 85
Reverse 5¢-TGGACGTGTTCAGCTGATGAC-3¢
LPL Forward 5¢-GACCAAGGTAGACCAGCCATTC-3¢ 136
Reverse 5¢-CACCAATGTCCACTTCTGTGTAGAT-3¢
HIP1 Forward 5¢-ACCGTCAAGCTGCTCTTCAAAC-3¢ 114
Reverse 5¢-TGGAGCGATAGAAGAGGTCCTT-3¢
CD4 Forward 5¢-GAGTGGCCCAGCAGGGATA-3¢ 113
Reverse 5¢-CAGTTAAATCACTCTGGGCAGTACA-3¢
CD1b Forward 5¢-TTGCAGCCTGTGTGGATCTG-3¢ 66
Reverse 5¢-TGCATGAGATGACTGCAAAGG-3¢
CD1c Forward 5¢-AGCAGGCTGGTGCAGATGTA-3¢ 121
Reverse 5¢-TGGCCCTCGTAAGCAATGTC-3¢
CD83 Forward 5¢-CACCCTGTGCAATGTTTGGA-3¢ 73
Reverse 5¢-CAAAGCATGTCACAGCAACATCT-3¢
pp38 Forward 5¢- GAAAACAGAAGCGGAATGCG-3¢ 69
Reverse 5¢-CGATCCAAAGCGCTCATCTC-3¢
HMBS Forward 5¢-GGTTGAGATGCTCCGTGAGTTT-3¢ 153
Reverse 5¢-GGCTCTTCTCCCCAATCTTAGAA-3¢
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cDNA library preparation and RNA-seq
Total RNA was processed to make cDNA libraries using
TruSeq Technology according to the manufacturer’s
instructions (Illumina, San Diego, CA) and four libraries
were subsequently sequenced by using Illumina HiSeq2500.
Data filtering, mapping reads and transcriptome
analysis
In order to filter the data, adaptor sequences were removed
and poor quality reads (lower than Q20) were discarded
using cutadapt v1.4.1 with default parameters. Non-redun-
dant reads were then mapped to the Gallus gallus and gallid
herpesvirus 2 (MDV type 1) reference genome sequences
with TopHat-2.0 using default settings [49]. The Gallus gal-
lus reference genome sequence and gene structure informa-
tion (GTF, general transfer format) were downloaded from
the ensembl database (release 74). The MDV genome
sequence and annotation were fetched from the NCBI FTP
database (accession id: NC_002229). HTseq-count of
HTSeq-0.5.3 [50] was then used to sum the read counts for
each gene to generate expression levels. Moreover, CPM val-
ues were obtained and used to normalize the counts and
the edgeR statistical package and an over-dispersed Poisson
model were used to determine significant differences in
gene counts across negative and positive samples to account
for variability in gene expression [51]. DE genes filtered at
FDR <0.05 were then mapped to known pathways/gene
ontology terms and their biological functions determined.
Data were analysed by using IPA [52] by importing gene
accession numbers along with the corresponding expression
P-values and log fold-change values. The IPA ‘core analysis’
function was used to interpret data in the context of biologi-
cal functions, pathways and gene regulation networks.
RT-qPCR validation of gene expression
RT-qPCR analysis was performed on an ABI Model 7500
Real-Time instrument (Applied Biosystems, Foster City,
CA, USA) using the Verso 1-step SYBR Green RT-qPCR kit
plus Rox system (Thermo scientific, Waltham, MA, USA)
according to the manufacturer’s instructions. Briefly, RNA
(12.5 ng) was mixed with 6.5 µl of 21 Step qPCR mix,
0.5 µl enhancer, 0.1 µl enzyme and 1 µl of mixed forward
and reverse primers at 1 µM working concentration, in a
13 µl final reaction volume. RT-qPCR conditions were as
follows: one cycle, 50

C for 30min, 95

C for 15min fol-
lowed by 40 cycles of 95

C for 15 s, 60

C for 30 s and 72

C
for 30 s. Gene changes were determined using the 2 DDCt
method [53] by normalizing to hydroxymethylbilane syn-
thase expression, which did not vary significantly in RNA
prepared from EGFP+ and EGFP  cells. Primer sequences
and further details regarding the primers are provided in
Table 2.
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